These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25405333)

  • 1. Implementation of maximin efficient designs in dose-finding studies.
    Fackle-Fornius E; Miller F; Nyquist H
    Pharm Stat; 2015; 14(1):63-73. PubMed ID: 25405333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust and efficient design of experiments for the Monod model.
    Dette H; Melas VB; Pepelyshev A; Strigul N
    J Theor Biol; 2005 Jun; 234(4):537-50. PubMed ID: 15808874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized maximim
    Chen PY; Chen RB; Tung HC; Wong WK
    Chemometr Intell Lab Syst; 2017 Oct; 169():79-86. PubMed ID: 29332979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal designs for a multiresponse Emax model and efficient parameter estimation.
    Magnusdottir BT
    Biom J; 2016 May; 58(3):518-34. PubMed ID: 26467148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximin D-optimal designs for longitudinal mixed effects models.
    Ouwens MJ; Tan FE; Berger MP
    Biometrics; 2002 Dec; 58(4):735-41. PubMed ID: 12495127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive designs for dose-finding studies based on sigmoid Emax model.
    Dragalin V; Hsuan F; Padmanabhan SK
    J Biopharm Stat; 2007; 17(6):1051-70. PubMed ID: 18027216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficient designs for observational epidemiologic studies.
    Kalish LA; Begg CB
    Biometrics; 1987 Mar; 43(1):145-67. PubMed ID: 3567303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal design for nonlinear estimation of the hemodynamic response function.
    Maus B; van Breukelen GJ; Goebel R; Berger MP
    Hum Brain Mapp; 2012 Jun; 33(6):1253-67. PubMed ID: 21567658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioassay case study applying the maximin D-optimal design algorithm to the four-parameter logistic model.
    Coffey T
    Pharm Stat; 2015; 14(5):427-32. PubMed ID: 26235135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal dose-finding designs with correlated continuous and discrete responses.
    Fedorov V; Wu Y; Zhang R
    Stat Med; 2012 Feb; 31(3):217-34. PubMed ID: 22162014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximin design of cluster randomized trials with heterogeneous costs and variances.
    van Breukelen GJP; Candel MJJM
    Biom J; 2021 Oct; 63(7):1444-1463. PubMed ID: 34247406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian optimal adaptive designs for delayed-response dose-finding studies.
    Li W; Fu H
    J Biopharm Stat; 2011 Sep; 21(5):888-901. PubMed ID: 21830921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.
    Thomas N
    J Biopharm Stat; 2006; 16(5):657-77. PubMed ID: 17037264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studies.
    Yan Z; Hosmane B; Locke C
    J Biopharm Stat; 2013; 23(4):804-17. PubMed ID: 23786490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximin optimal designs for cluster randomized trials.
    Wu S; Wong WK; Crespi CM
    Biometrics; 2017 Sep; 73(3):916-926. PubMed ID: 28182835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal designs for estimating the interesting part of a dose-effect curve.
    Miller F; Guilbaud O; Dette H
    J Biopharm Stat; 2007; 17(6):1097-115. PubMed ID: 18027219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal plus one point designs for testing lack of fit for some sigmoid curve models.
    Su Y; Raghavarao D
    J Biopharm Stat; 2013 Mar; 23(2):281-93. PubMed ID: 23437939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A graphical method for finding maximin efficiency designs.
    Imhof L; Wong WK
    Biometrics; 2000 Mar; 56(1):113-7. PubMed ID: 10783784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pragmatic approach to the design of population pharmacokinetic studies.
    Roy A; Ette EI
    AAPS J; 2005 Oct; 7(2):E408-20. PubMed ID: 16353920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the efficiency of two-stage response-adaptive designs.
    Dette H; Bornkamp B; Bretz F
    Stat Med; 2013 May; 32(10):1646-60. PubMed ID: 22865374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.